These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19240773)

  • 1. [Risk of urolithiasis in patients with cystic fibrosis].
    Campuzano S; Díaz JJ; Bousoño C; Rodríguez M; Campos C; Málaga S
    Nefrologia; 2009; 29(1):61-6. PubMed ID: 19240773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a risk for kidney stone formation in cystic fibrosis?
    Böhles H; Michalk D
    Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis.
    Böhles H; Gebhardt B; Beeg T; Sewell AC; Solem E; Posselt G
    J Pediatr; 2002 Jan; 140(1):103-9. PubMed ID: 11815772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
    Dobson L; Stride A; Bingham C; Elworthy S; Sheldon CD; Hattersley AT
    Pediatr Pulmonol; 2005 Feb; 39(2):103-7. PubMed ID: 15573388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population.
    Watts KD; Seshadri R; Sullivan C; McColley SA
    Pediatr Pulmonol; 2009 Jun; 44(6):594-601. PubMed ID: 19437506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
    Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
    J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for small bowel bacterial overgrowth in cystic fibrosis.
    Fridge JL; Conrad C; Gerson L; Castillo RO; Cox K
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):212-8. PubMed ID: 17255834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis and calcium oxalate nephrolithiasis.
    Chidekel AS; Dolan TF
    Yale J Biol Med; 1996; 69(4):317-21. PubMed ID: 9273985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.
    Fluge G; Olesen HV; Gilljam M; Meyer P; Pressler T; Storrösten OT; Karpati F; Hjelte L
    J Cyst Fibros; 2009 May; 8(3):198-202. PubMed ID: 19303374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth assessment of paediatric patients with CF comparing different auxologic indicators: A multicentre Italian study.
    Lucidi V; Alghisi F; Raia V; Russo B; Valmarana L; Valmarana R; Coruzzo A; Beschi S; Dester S; Rinaldi D; Maglieri M; Guidotti ML; Ravaioli E; Pesola M; De Alessandri A; Padoan R; Grynzich L; Ratclif L; Repetto T; Ambroni M; Provenzano E; Tozzi AE; Colombo C
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):335-42. PubMed ID: 19543116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
    Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
    Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MRI-based flow measurements in the main pulmonary artery to detect pulmonary arterial hypertension in patients with cystic fibrosis].
    Wolf T; Anjorin A; Posselt H; Smaczny C; Vogl TJ; Abolmaali N
    Rofo; 2009 Feb; 181(2):139-46. PubMed ID: 19101881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.
    Rovner AJ; Zemel BS; Leonard MB; Schall JI; Stallings VA
    J Pediatr; 2005 Sep; 147(3):327-31. PubMed ID: 16182670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
    Hamid R; Robertson WG; Woodhouse CR
    BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations.
    Newport S; Amin N; Dozor AJ
    Pediatr Pulmonol; 2009 Sep; 44(9):866-72. PubMed ID: 19670404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of hope in cystic fibrosis patients: a comparison with the general population.
    Rustøen T; Wahl AK; Hanestad BR; Gjengedal E; Moum T
    Heart Lung; 2004; 33(2):111-8. PubMed ID: 15024376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients.
    Al-Aloul M; Jackson M; Bell G; Ledson M; Walshaw M
    J Cyst Fibros; 2007 Jan; 6(1):41-7. PubMed ID: 16807143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.